Health TrialsbyHealthPanel

Pilot Testing of a Colorectal Cancer Education Program

ConditionColorectal Cancer Screening
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-75
SponsorNYU Langone Health

About this trial

The primary objective of this study is to assess the feasibility, acceptability, and preliminary efficacy of a culturally and linguistically targeted, colorectal cancer (CRC) education program to improve CRC screening completion.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 45-75 years

Not guideline concordant (no stool testing for CRC within past 1 year)

No colonoscopy in past 10 years; no sigmoidoscopy or CT colonography in past 5 years)

Understands English or Chinese languages.

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Educational Program

    Behavioral

    Culturally and linguistically tailored program consisting of community health worker (CHW)-led education sessions followed by patient navigation (PN) services.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Adults due for CRC screening who speak English or a Chinese language (Cantonese/Mandarin)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

CRC screening completion (yes/no)

Time frame
Month 6

Secondary outcomes

1

Change in Brief Illness Perception Questionnaire (IPQ-B) score

The IPQ-B is a 9-item questionnaire (validated in the Chinese population) that assesses CRC beliefs according to CRC beliefs according to SRM constructs (SRM) constructs. Each item is rated on a scale from 0 (strong disagree) to 10 (strongly agree). Total scores range from 0-90, with higher scores indicating a greater threat and worse perception of illness.

Time frame
Baseline, Month 6
2

Change in Medicines Questionnaire (BMQ) score

The BMQ, validated in the Chinese population, adapted to assess concerns/necessity of CRC screening is a 5 items questionnaire. Items are assessed on a scale from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 5-25, with higher scores indicating positive beliefs about CRC screening.

Time frame
Baseline, Month 6
3

Change in number of barriers to care

Participants re asked to select all that apply to barriers in care: Cost, Transportation, Lack of time, Fear of results, Embarrassment, Lack of trust in doctors, Language barriers, Other. Each item selected is counted, a decrease in the number of items selected indicates reduced barriers to care.

Time frame
Baseline, Month 6
4

Change in trust in health/community health workers

Group-based medical mistrust scale consists of 2 statements of mistrust and 2 statements of trust. Each statement can be answered with 1) Strongly Disagree, 2) Disagree, 3) Neither Agree nor Disagree, 4) Agree, 5) Strongly Agree.

Time frame
Baseline, Month 6

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

NYU Langone Health

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov
Apply now